ArticleFrontiers in cellular and infection microbiology2026
Development and evaluation of a recombinase-aided amplification-lateral flow dipstick assay for rapid and sensitive detection of
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: According to the design rules for RAA primers and exo-probes, specific primers and a probe were designed targeting the conserved region of the MS Results: The RAA reaction was completed within 20 min at a constant temperature of 37 °C, and amplification products were visually read within 3-5 min using a lateral flow dipstick without sophisticated equipment. The total detection time, including the DNA extraction step, is completed within 40 min. Methodological validation revealed that the RAA-LFD assay exhibited high specificity, with no cross-reactivity observed against other common avian pathogens. The assay also showed satisfactory repeatability and high sensitivity, with a limit of detection of 2.63×10 Conclusion: In summary, the established RAA-LFD assay is rapid, user-friendly, highly specific, and sensitive. To further improve the RAA-LFD-MS assay for routine clinical and field use, future efforts should prioritize the optimization of rapid DNA extraction, accessible temperature-control devices, and reagent lyophilization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.